Mary Cardone

Molecule2Market

Molecule2Market are a team of experienced clinical research professionals working with clients to achieve their research goals in Australia, Asia-Pacific region and the USA. We are dedicated to advancing the contribution to the research and development of innovative medical treatments. A privately owned Australian CRO (Clinical Research Organisation), we provide
 contract services to the pharmaceutical and biotechnology industries looking to perform clinical research 
in the region including Asia-Pacific. Our USA business team works with local and international clients across all facets of clinical research in multiple therapeutic areas. Combining the strength of our expertise and extensive experience (our directors' have over 70 years' collective experience), we provide high quality services across all phases of clinical research in a broad range of therapeutic areas.